Internal Medicine · San Francisco, CA
NPI
1063524122
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
995 Potrero Avenue, Bldg 80 Ward 84
San Francisco, CA, 94110
Phone (415) 476-4082
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
272 services
Medicare patients, 2024
81
Average age 65
Drug cost, 2024
$1.5M
2,903 prescriptions
Company payments, 2024
$17.44
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Royce C Lin was code 99214 (office e&m - established), 53 times for 39 patients. In total Royce C Lin billed 272 services in 27 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 53 | 39 | $99.65 | $5,282 |
| 99213 Office E&M - Established | Office | 38 | 29 | $63.01 | $2,394 |
| 90480 Vaccine Administration | Office | 26 | 24 | $25.48 | $662 |
| 99215 Office E&M - Established | Office | 23 | 16 | $138.98 | $3,197 |
| 91320 Vaccine Product | Office | 16 | 16 | $152.78 | $2,444 |
| G0008 Administration of influenza virus vaccine | Office | 16 | 16 | $1.96 | $31.36 |
By year: 2022 $41K for 1,080 services; 2023 $21K for 343 services; 2024 $20K for 272 services.
Medicare prescription drug claims, 2024
In 2024, the drug Royce C Lin prescribed most often to Medicare patients was Gabapentin, with 149 prescriptions and refills. In total Royce C Lin wrote 2,903 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 149 | 158 | 23 | $2,331 |
| Estradiol Generic | 119 | 151 | 18 | $1,627 |
| Atorvastatin Calcium Generic | 115 | 173 | 24 | $747 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 98 | 98 | 14 | $382K |
| Pantoprazole Sodium Generic | 80 | 97 | 12 | $733 |
| Spironolactone Generic | 78 | 98 | 13 | $947 |
| Finasteride Generic | 76 | 108 | 13 | $759 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 74 | 74 | Under 11 | $282K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 74 | 74 | Under 11 | $855 |
| Amlodipine Besylate Generic | 69 | 103 | 18 | $316 |
| Metformin Hcl Er Metformin Hcl | 68 | 89 | Under 11 | $366 |
| Benazepril Hcl Generic | 66 | 106 | 13 | $504 |
| Oxycodone Hcl Generic | 64 | 64 | 14 | $1,422 |
| Metoprolol Succinate Generic | 62 | 80 | Under 11 | $1,127 |
| Levothyroxine Sodium Generic | 54 | 84 | Under 11 | $337 |
Brand drugs: - claims; generic drugs: 2,255 claims; opioid claims: 210.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Royce C Lin $17.44 ($17.44 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $17.44.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $17.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.